Is Nkarta (NKTX) Stock Halal?
Compliance Status
Not Halal
Screened on Nov 10, 2026 · AAOIFI Standard 21
Non-Compliant
Is Nkarta, Inc. (NKTX) halal? Not Halal. Based on AAOIFI screening, Nkarta, Inc. passes the business activity screen but fails financial ratio screens with a compliance score of 0/100 (Grade: F).
Quote this verdict
HalalScreener rates Nkarta, Inc. (NKTX) Not Halal, 0/100, grade F under AAOIFI Standard 21, screened Nov 10, 2026. Source: https://halalscreener.app/en/stock/NKTX
Business activity
What the company sells is permissible.
Company debt
Over the limitHow much the company borrows, compared to its total value. AAOIFI allows up to 30%.
The verdict above is final and free.
Pro members can verify every number behind it: interest-bearing deposits, prohibited income breakdown, and the full AAOIFI math.
Screened according to AAOIFI Standard 21
What this means for you
Most scholars advise not holding NKTX
It does not pass AAOIFI Shariah screening.
See halal alternatives from the same sector further down this page
Share this verdict
A receipt-style image with the math on it, so whoever you send it to can check it.

NKTX
Nkarta, Inc.
$1.31
Market Cap: 94.2M
Screened on a market cap of 113.9M
Get an email if NKTX's halal status changes
We re-screen Nkarta, Inc. daily. If the verdict moves, you hear about it the same day.
Free. One click sets it up, and you can unsubscribe any time.
About Nkarta, Inc.
Nkarta, Inc., a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. Its lead product candidate is NKX019, a chimeric antigen receptor-natural killer (CAR NK) targeting the CD19 antigen, which is in Phase 1 clinical trial for the treatment of lupus nephritis; systemic sclerosis; idiopathic inflammatory myopathy; and antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, as well as for systemic lupus erythematosus and myasthenia gravis. The company has a research collaboration agreement with CRISPR Therapeutics AG. Nkarta, Inc. was incorporated in 2015 and is based in South San Francisco, California.
Sector: Healthcare · Industry: Biotechnology
Why this does not pass
- Interest-bearing debt is 63.3% of market cap, over the 30% AAOIFI limit.
- Interest-bearing deposits are over the 30% limit.
Screened under AAOIFI Standard 21. The exact figure behind this is part of Pro; the failing check and its limit are always free.
Shariah Compliance Status
Compliance History
Not Halalnow
since Aug 2026
Under Review
until the change above
Tracked since Aug 2026. Updates automatically on each re-screen.
Halal Alternatives in Healthcare
This stock is not Shariah-compliant. Here are halal alternatives from the same sector, ranked by compliance score:
More Healthcare Stocks
Know the day NKTX's verdict changes
A free account keeps watch on 3 stocks and emails you when a verdict moves. You also get 3 questions for the AI Scholar. No card needed.
Frequently Asked Questions
Is Nkarta, Inc. (NKTX) halal to invest in?
Why did Nkarta, Inc. get a F compliance rating?
What could change Nkarta, Inc.'s Shariah verdict?
How often is Nkarta, Inc. re-screened for Shariah compliance?
Screened according to AAOIFI Standard No. 21 · For informational purposes only. Consult a qualified Islamic finance advisor before investing.
Disclaimer: This screening is for informational purposes only and does not constitute financial, legal, or religious advice. Compliance is evaluated using AAOIFI financial standards (debt, deposits, and prohibited income ratios) and publicly available data. Ethical, political, social, or environmental considerations are outside the scope of this screening. Individual scholars and methodologies may differ. Always consult a qualified Islamic finance advisor before making investment decisions.
